Matches in Wikidata for { <http://www.wikidata.org/entity/Q74118693> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q74118693 description "artículu científicu espublizáu en mayu de 2000" @default.
- Q74118693 description "im Mai 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74118693 description "scientific article published on 01 May 2000" @default.
- Q74118693 description "wetenschappelijk artikel" @default.
- Q74118693 description "наукова стаття, опублікована в травні 2000" @default.
- Q74118693 name "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies" @default.
- Q74118693 name "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies" @default.
- Q74118693 type Item @default.
- Q74118693 label "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies" @default.
- Q74118693 label "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies" @default.
- Q74118693 prefLabel "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies" @default.
- Q74118693 prefLabel "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies" @default.
- Q74118693 P1433 Q74118693-5E72FD0C-0E93-4707-A822-324F00DED369 @default.
- Q74118693 P1476 Q74118693-12519856-6D5E-489F-8886-A077FF33350D @default.
- Q74118693 P2093 Q74118693-1A4F9A21-A6DD-4A8E-8F9C-89C69F6238EF @default.
- Q74118693 P2093 Q74118693-342A144D-256E-4A7F-8124-C77037016D3D @default.
- Q74118693 P2093 Q74118693-D5F97312-5F8F-436B-B55B-7C929B4C2982 @default.
- Q74118693 P2093 Q74118693-EAD5351F-C133-46DB-A21E-6F3582DCCF5D @default.
- Q74118693 P304 Q74118693-E3F1A6DE-E10E-4E10-9160-4EFD0CAD297B @default.
- Q74118693 P31 Q74118693-C6B5D1E6-354D-4978-9650-ABBFE98A7ED6 @default.
- Q74118693 P407 Q74118693-D4CC3E58-5F9A-4104-9E73-789F60302706 @default.
- Q74118693 P433 Q74118693-0980C07E-6B6F-49E4-88CF-2797C0CFE651 @default.
- Q74118693 P478 Q74118693-F1F62A4C-FFE8-4E6B-B930-6473B58D1C5B @default.
- Q74118693 P577 Q74118693-D8BC7801-6BE9-4597-8BF7-FF0FF1DAC46B @default.
- Q74118693 P698 Q74118693-BB49A1C7-0F6B-4438-98F8-0246AF870601 @default.
- Q74118693 P698 10928160 @default.
- Q74118693 P1433 Q326290 @default.
- Q74118693 P1476 "A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies" @default.
- Q74118693 P2093 "Bolis S" @default.
- Q74118693 P2093 "Brivio F" @default.
- Q74118693 P2093 "Fumagalli L" @default.
- Q74118693 P2093 "Lissoni P" @default.
- Q74118693 P304 "2103-2105" @default.
- Q74118693 P31 Q13442814 @default.
- Q74118693 P407 Q1860 @default.
- Q74118693 P433 "3B" @default.
- Q74118693 P478 "20" @default.
- Q74118693 P577 "2000-05-01T00:00:00Z" @default.
- Q74118693 P698 "10928160" @default.